We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Strategy Inc
MSTR
$33.5B
| $27.6M | 0.08% |
1,301,000
+461,000
| +55% | +$11.6M |
|
|
ABMD
252
DELISTED
Abiomed Inc
ABMD
| $27.4M | 0.08% |
111,499
-23,200
| -17% | -$6.26M |
|
253
Okta
OKTA
$24.1B
| $27M | 0.08% |
475,560
+268,200
| +129% | +$23.1M |
|
254
Freeport-McMoran
FCX
$90B
| $27M | 0.08% |
986,500
-67,600
| -6% | -$1.98M |
|
255
Johnson Controls International
JCI
$87.5B
| $26.9M | 0.08% |
545,700
-50,400
| -8% | -$2.67M |
|
256
Home Depot
HD
$332B
| $26.6M | 0.08% |
96,500
+77,500
| +408% | +$22.9M |
|
257
Tencent Music
TME
$14.5B
| $26.6M | 0.08% |
6,544,100
-367,100
| -5% | -$1.67M |
|
258
Allegion
ALLE
$13B
| $26.2M | 0.08% |
292,700
+50,900
| +21% | +$5.04M |
|
259
AbbVie
ABBV
$458B
| $25.9M | 0.08% |
192,966
-152,000
| -44% | -$21.8M |
|
260
Tapestry
TPR
$28.8B
| $25.8M | 0.07% |
907,380
-325,100
| -26% | -$10.9M |
|
261
Trex
TREX
$4.51B
| $25.7M | 0.07% |
585,900
+412,300
| +238% | +$22.1M |
|
262
J.M. Smucker
SJM
$12.6B
| $25.7M | 0.07% |
186,700
-16,800
| -8% | -$2.29M |
|
263
Haemonetics
HAE
$3.58B
| $25.6M | 0.07% |
346,455
-64,900
| -16% | -$4.66M |
|
264
ASML
ASML
$675B
| $25.6M | 0.07% |
61,600
-11,400
| -16% | -$5.71M |
|
265
IPG Photonics
IPGP
$3.89B
| $25.5M | 0.07% |
302,600
-103,900
| -26% | -$9.87M |
|
266
BioCryst Pharmaceuticals
BCRX
$2.37B
| $25.4M | 0.07% |
2,015,812
-67,600
| -3% | -$870K |
|
267
Comstock Resources
CRK
$3.97B
| $25.4M | 0.07% |
1,466,600
-3,700
| -0.3% | -$61.2K |
|
268
Seagate
STX
$193B
| $25.3M | 0.07% |
474,900
-26,400
| -5% | -$1.91M |
|
269
Alpha Metallurgical Resources
AMR
$1.82B
| $25.2M | 0.07% |
184,500
-162,000
| -47% | -$22.5M |
|
270
T. Rowe Price
TROW
$25B
| $25.1M | 0.07% |
238,800
+145,300
| +155% | +$17.3M |
|
271
Alkermes
ALKS
$8.82B
| $25M | 0.07% |
1,119,700
-77,600
| -6% | -$2.02M |
|
272
Asana
ASAN
$1.58B
| $24.9M | 0.07% |
1,121,900
-428,100
| -28% | -$9.18M |
|
273
iShares Russell 1000 Growth ETF
IWF
$122B
| $24.8M | 0.07% |
472,400
-220,000
| -32% | -$12.9M |
|
274
Synaptics
SYNA
$4.41B
| $24.8M | 0.07% |
250,520
+102,100
| +69% | +$12.7M |
|
275
Xerox
XRX
$337M
| $24.7M | 0.07% |
1,888,650
-513,900
| -21% | -$8.32M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.